Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

http://www.businessweek.com/ap/2012-11-19/oxycontin-generic-approval-proceeds-in-canada

AP News

OxyContin generic approval proceeds in Canada


OTTAWA (AP) — Canada's federal government has allowed the approval process to proceed for the generic form of the highly addictive painkiller OxyContin, a move that set off a quick outcry from the country's provinces.

Health Minister Leona Aglukkaq rejected a plea Monday from Canada's provinces, which unanimously requested a delay of approval until regulators could examine how oxycodone is abused. Ontario asked for a complete ban on the drug, which has caused widespread addictions in Canada's rural and tribal communities.

Aglukkaq told a news conference that federal laws don't allow regulators to simply ban a drug just because some people abuse it.

Her refusal to get involved in the process opens the way for generic oxycodone to win approval in Canada after the patent for the brand-name OxyContin expires on Nov. 25.


The Aging of Abercrombie & Fitch
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus